Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1

Summary

Randomized, double-blind, placebo-controlled, 16-week study designed to explore the safety and efficacy of IMC-1 for the treatment of patients with fibromyalgia.

Timeline

Start

2021-06-03

Primary completion

2022-08-05

Completion

2022-08-05

Publications

• Background Pridgen WL, Duffy C, Gendreau JF, Gendreau RM. A famciclovir + celecoxib combination treatment is safe and efficacious in the treatment of fibromyalgia. J Pain Res. 2017 Feb 22;10:451-460. doi: 10.2147/JPR.S127288. eCollection 2017.

Drugs

Indications